InvestorsHub Logo
Followers 14
Posts 396
Boards Moderated 0
Alias Born 12/18/2014

Re: DewDiligence post# 37065

Wednesday, 10/04/2017 9:49:16 AM

Wednesday, October 04, 2017 9:49:16 AM

Post# of 108192

If the program were that good, ADXS would be planning additional trials, not looking to out-license it.


If HER2 trials weren't that good, should Lombardo simply discard the program rather than talking licensing it out? Perhaps you would agree that a typical man with age in the 70s would care more of building his legacy rather than on financial gain by lying.

I'm buying a bunch more ADXS shares at this level.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News